Exploring your options for Spinal Muscular Atrophy (SMA) in India? Ginger Healthcare brings together a carefully chosen panel of reputed neurologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Spinal Muscular Atrophy (SMA). Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Here are the most reputed hospitals in India for Spinal Muscular Atrophy (SMA). These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Spinal muscular atrophy (SMA) is a genetic neuromuscular condition in which motor neurons in the spinal cord gradually deteriorate, causing progressive muscle weakness affecting movement, breathing, and swallowing. It is caused by a deficiency of the SMN protein due to mutations in the SMN1 gene and ranges in severity from a life-threatening infantile form (Type 1) to a mild adult-onset form (Type 4). Over the past decade, three disease-modifying therapies — nusinersen (intrathecal injection), onasemnogene abeparvovec (one-time gene therapy), and risdiplam (daily oral medication) — have transformed outcomes, particularly when started early. Alongside these targeted treatments, comprehensive multidisciplinary supportive care addressing respiratory, nutritional, orthopaedic, and rehabilitation needs remains essential to maximise quality of life at every stage.
A medicine injected into the spinal fluid via lumbar puncture on a loading schedule and then every four months long-term, suitable across all ages and SMA types.
Estimated cost: ~$500 – $1,000
Typical tests: SMN1 deletion/mutation genetic test (if not already done), SMN2 copy number analysis, CBC and coagulation profile (PT/INR — required before lumbar puncture), Renal and liver function tests, CSF analysis (baseline, first visit), Motor function assessment (CHOP-INTEND or HFMSE as age-appropriate), MRI spine (to assess lumbar anatomy for injection planning, if not recent), Overnight pulse oximetry (respiratory baseline). Done in India before admission.
Estimated cost in India: $10,000 – $30,000
Treatment duration in India: ~2 months (~8 hospital visit days across the full span)
A single intravenous infusion that delivers a working copy of the SMN1 gene directly to motor neurons, primarily used in young children under eligibility criteria based on age and weight.
Estimated cost: ~$1,000 – $2,000
Typical tests: SMN1 deletion/mutation genetic confirmation, Anti-AAV9 antibody titre (mandatory eligibility test), CBC, liver function tests (LFT), and coagulation panel, Renal function and electrolytes, Cardiac evaluation — ECG and 2D echocardiogram, Motor function assessment (CHOP-INTEND), Troponin I (cardiac safety baseline), Ophthalmologic examination (intraocular pressure — steroid monitoring). Done in India before admission.
Estimated cost in India: $50,000 – $75,000
Pre-procedure stay (outside hospital): ~3 days
Hospitalisation: ~5 days
Recovery period (outside hospital): ~14 days recommended
Total stay: approx 22 days
A daily liquid medicine taken at home that increases SMN protein production through the SMN2 gene, approved for a wide age range from infants to adults with any type of SMA.
Estimated cost: ~$500 – $1,000
Typical tests: SMN1 deletion/mutation genetic confirmation (if not already done), SMN2 copy number analysis, CBC and differential, Liver function tests (LFT) and renal function, Ophthalmologic examination (fundoscopy — retinal safety monitoring required for risdiplam), Motor function assessment (CHOP-INTEND, HFMSE, or MFM as age-appropriate), Pulmonary function test or overnight oximetry (respiratory baseline), Pregnancy test (females of childbearing potential). Done in India before admission.
Estimated cost in India: $3,000 – $8,000
Treatment duration in India: ~2 weeks (~4 hospital visit days across the full span)
A structured programme of respiratory management, physiotherapy, nutritional support, and orthopaedic monitoring for patients who are not yet on disease-modifying therapy or need comprehensive care alongside it.
Estimated cost: ~$500 – $1,500
Typical tests: SMN1/SMN2 genetic confirmation (if not already done), CBC, LFT, renal function, vitamin D, and calcium levels, Pulmonary function tests (spirometry, peak cough flow), Overnight pulse oximetry and/or polysomnography, Spine X-ray (AP and lateral, for scoliosis assessment), DEXA bone density scan (for children and adults with limited weight-bearing), Swallowing assessment (videofluoroscopy or clinical swallow evaluation), Motor function assessment (CHOP-INTEND, HFMSE, or 6MWT as age-appropriate). Done in India before admission.
Estimated cost in India: $3,000 – $7,000
Treatment duration in India: ~2 weeks (~10 hospital visit days across the full span)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
